KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Rigel Pharmaceuticals (RIGL) over the last 17 years, with Q3 2025 value amounting to $1.2 million.

  • Rigel Pharmaceuticals' Other Non-Current Assets fell 7548.83% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 7548.83%. This contributed to the annual value of $1.4 million for FY2024, which is 5302.78% down from last year.
  • Rigel Pharmaceuticals' Other Non-Current Assets amounted to $1.2 million in Q3 2025, which was down 7548.83% from $4.2 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Other Non-Current Assets high stood at $5.0 million for Q3 2023, and its period low was $403000.0 during Q2 2022.
  • Moreover, its 5-year median value for Other Non-Current Assets was $974000.0 (2021), whereas its average is $1.9 million.
  • In the last 5 years, Rigel Pharmaceuticals' Other Non-Current Assets surged by 92396.69% in 2023 and then crashed by 7548.83% in 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $974000.0 in 2021, then plummeted by 34.29% to $640000.0 in 2022, then surged by 377.34% to $3.1 million in 2023, then crashed by 53.03% to $1.4 million in 2024, then decreased by 18.68% to $1.2 million in 2025.
  • Its Other Non-Current Assets stands at $1.2 million for Q3 2025, versus $4.2 million for Q2 2025 and $1.5 million for Q1 2025.